Alterations of the CARD15/NOD2 Gene and the Impact on Management and Treatment of Crohn's Disease Patients

Digestive Diseases

Volumn 21, Issue 4, 2003, Pages 339-345

  Török, Helga Paula ^a   Glas, Jürgen ^a   Lohse, Peter ^a   Folwaczny, Christian ^a,b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

CARD15 NOD2; Crohn's disease; Genotype, clinical implications; Mutations

Indexed keywords

AMINOSALICYLIC ACID; CASPASE RECRUITMENT DOMAIN PROTEIN 15; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

CAUCASIAN; CROHN DISEASE; ENTERITIS; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HIGH RISK POPULATION; HUMAN; ILEUM DISEASE; IMMUNITY; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; REVIEW;

APOPTOSIS; CARRIER PROTEINS; CROHN DISEASE; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NOD2 SIGNALING ADAPTOR PROTEIN;

EID: 1142310558     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075357     Document Type: Review

References (65)

1. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B: Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins: A study of heritability and the influence of smoking. Gut 1988;29:990-996.
2. Thompson NP, Driscoll R, Pounder RE, Wakefield AJ: Genetics versus environment in inflammatory bowel disease: Results of a British twin study. BMJ 1996;312:95-96.
3. Subhani J, Montgomery SM, Ounder RE, Wakefield AJ: Concordance rates of twins and siblings in inflammatory bowel disease. Gut 1998;42:A40.
4. Halfvarson J, Bodin L, Tysk C, Lindberg E, Jarnerot G: Inflammatory bowel disease in a Swedish twin cohort: A long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003;124:1767-1773.
5. Farmer RG, Michener WM, Mortimer EA: Studies of family history among patients with inflammatory bowel disease. Clin Gastroenterol 1980;9:271-277.
6. Monsen U, Bernell O, Johansson C, Hellers G: Prevalence of inflammatory bowel disease among relatives of patients with Crohn's disease. Scand J Gastroenterol 1991;26:302-306.
7. Russel MG, Pastoor CJ, Janssen KM, van Deursen CT, Muris JW, van Wijlick EH, Stockbrugger RW: Familial aggregation of inflammatory bowel disease: A population-based study in South Limburg, The Netherlands. The South Limburg IBD Study Group. Scand J Gastroenterol Suppl 1997;223:88-91.
8. Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen IA, Binder V: Familial occurrence of inflammatory bowel disease. N Engl J Med 1991;324:84-88.
9. Peeters M, Nevens H, Baert F, Hiele M, de Meyer AM, Vlietinck R, Rutgeerts P: Familial aggregation in Crohn's disease: Increased ageadjusted risk and concordance in clinical characteristics. Gastroenterology 1996;111:597-603.
10. Sonnenberg A, Wasserman ICH: Epidemiology of inflammatory bowel disease among US military veterans. Gastroenterology 1991;101:122-130.
11. Kurata JH, Kantor-Fish S, Frankl H, Godby P, Vadheim CM: Crohn's disease among ethnic groups in a large health maintenance organization. Gastroenterology 1992;102:1940-1948.
12. Ogunbi SO, Ransom JA, Sullivan K, Schoen BT, Gold BD: Inflammatory bowel disease in African-American children living in Georgia. J Pediatr 1998;133:103-107.
13. Yang SK, Loftus EV Jr, Sandborn WJ: Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis 2001;7:260-270.
14. Roth MP, Petersen GM, McElree C, Vadheim CM, Panish JF, Rotter JI: Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology 1989;96:1016-1020.
15. Yang H, Taylor KD, Rotter JI: Inflammatory bowel disease. I. Genetic epidemiology. Mol Genet Metab 2001;74:1-21.
16. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
17. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-606.
18. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, Bridger S, van Deventer S, Forbes A, Nikolaus S, Lennard-Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG; Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001;357:1925-1928.
19. Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS, Thomas G, Hugot JP; EPWG-IBD Group; EPIMAD Group; GETAID Group: CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:845-857.
20. Ahmad T, Armuzzi A, Bunce M, Mulcahy-Hawes K, Marshall SE, Orchard TR, Crawshaw J, Large O, de Silva A, Cook JT, Barnardo M, Cullen S, Welsh KI, Jewell DP: The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002;122:854-866.
21. Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJ, Mascheretti S, Sanderson J, Forbes A, Mansfield J, Schreiber S, Lewis CM, Mathew CG: The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002;122:867-874.
22. Vavassori P, Borgiani P, D'Apice MR, De Negris F, Del Vecchio Blanco G, Monteleone I, Biancone L, Novelli G, Pallone E: 3020insC mutation within the NOD2 gene in Crohn's disease: Frequency and association with clinical pattern in an Italian population. Dig Liver Dis: 2002;34:153.
23. Murillo L, Crusius JB, van Bodegraven AA, Alizadeh BZ, Pena AS: CARD15 gene and the classification of Crohn's disease. Immunogenetics 2002;54:59-61.
24. Vermeire S, Wild G, Kocher K, Cousineau J, Dufresne L, Bitton A, Langelier D, Pare P, Lapointe G, Cohen A, Daly MJ, Rioux JD: CARD15 genetic variation in a Quebec population: Prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 2002;71:74-83.
25. Radlmayr M, Torok HP, Martin K, Folwaczny C: The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology 2002;122:2091-2092.
26. Bonen DK, Ogura Y, Nicolae DL, Inohara N, Saab L, Tanabe T, Chen FF, Foster SJ, Duerr RH, Brant SR, Cho JH, Nunez G: Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 2003;124:140-146.
27. Cavanaugh JA, Adams KE, Quak EJ, Bryce ME, O'Callaghan NJ, Rodgers HJ, Magarry GR, Butler WJ, Eaden JA, Roberts-Thomson IC, Pavli P, Wilson SR, Callen DF: CARD15/NOD2 risk alleles in the development of Crohn's disease in the Australian population. Ann Hum Genet 2003;67:35-41.
28. Bairead E, Harmon DL, Curtis AM, Kelly Y, O'Leary C, Gardner M, Leahy DT, Vaughan P, Keegan D, O'Morain C, O'Donoghue D, Shanahan F, Parfrey NA, Quane KA: Association of NOD2 with Crohn's disease in a homogenous Irish population. Eur J Hum Genet 2003;11:237-244.
29. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE, Cortot A, Colombel JF, Thomas G: Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996;379:821-823.
30. Cavanaugh J: IBD International Genetics Consortium: International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. Am J Hum Genet 2001;68:1165-1171.
31. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G: Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001;276:4812-4818.
32. Bonen DK, Cho JH: The genetics of inflammatory bowel disease. Gastroenterology 2003;124:521-536.
33. Inoue N, Tamura K, Kinouchi Y, Fukuda Y, Takahashi S, Ogura Y, Inohara N, Nunez G, Kishi Y, Koike Y, Shimosegawa T, Shimoyama T, Hibi T: Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002;123:86-91.
34. Yamazaki K, Takazoe M, Tanaka T, Kazumori T, Nakamura Y: Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet 2002;47:469-472.
35. Sugimura M, Kinouchi Y, Takahashi S, Aihara H, Takagi S, Negoro K, Obana N, Kojima Y, Matsumoto K, Kikuchi T, Hiroki M, Oomori S, Shimosegawa T: CARD15/NOD2 mutational analysis in Japanese patients with Crohn's disease. Clin Genet 2003;63:160-162.
36. Croucher PJ, Mascheretti S, Hampe J, Huse K, Frenzel H, Stoll M, Lu T, Nikolaus S, Yang SK, Krawczak M, Kim WH, Schreiber S: Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet 2003;11:6-16.
37. Leong RW, Armuzzi A, Ahmad T, Wong ML, Tse P, Jewell DP, Sung JJ: NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther 2003;17:1465-1470.
38. Bonen DK, Nicolae DL, Moran T, Turkyilmaz MA, Ramos R, Karaliukas R, Brant SR, Duerr RH, Kirschner BS, Hanauer SB, Cho JH: Racial Differences in NOD2 variation: Characterization of NOD2 in African-Americans with Crohn's disease. Gastroenterology 2002;122:A-29.
39. Zhou Z, Lin XY, Akolkar PN, Gulwani-Akolkar B, Levine J, Katz S, Silver J: Variation at NOD2/CARD15 in familial and sporadic cases of Crohn's disease in the Ashkenazi Jewish population. Am J Gastroenterol 2002;97:3095-3101.
40. Linde K, Boor PP, Houwing-Duistermaat JJ, Kuipers EJ, Wilson JH, de Rooij FW: Card15 and Crohn's disease: Healthy homozygous carriers of the 3020insC frameshift mutation. Am J Gastroenterol 2003;98:613-617.
41. Inohara N, Ogura Y, Nunez G: Nods: A family of cytosolic proteins that regulate the host response to pathogens. Curr Opin Microbiol 2002;5:76-80.
42. Girardin SE, Sansonetti PJ, Philpott DJ: Intracellular vs. extracellular recognition of pathogens-common concepts in mammals and flies. Trends Microbiol 2002;10:193-199.
43. Gutierrez O, Pipaon C, Inohara N, Fontalba A, Ogura Y, Prosper F, Nunez G, Fernandez-Luna JL: Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem 2002;277:41701-41705.
44. Hisamatsu T, Suzuki M, Reinecker HC, Nadeau WJ, McCormick BA, Podolsky DK: CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 2003;124:993-1000.
45. Rosenstiel P, Fantini M, Brautigam K, Kuhbacher T, Waetzig GH, Seegert D, Schreiber S: TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 2003;12:1001-1009.
46. Berrebi D, Maudinas R, Hugot JP, Chamaillard M, Chareyre F, De Lagausie P, Yang C, Desreumaux P, Giovannini M, Cezard JP, Zouali H, Emilie D, Peuchmaur M: Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 2003;52:840-846.
47. Lala S, Ogura Y, Osborne C, Hor SY, Bromfield A, Davies S, Ogunbiyi O, Nunez G, Keshav S: Crohn's disease and the NOD2 gene: A role for Paneth cells. Gastroenterology 2003;125:47-57.
48. Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F, Bui TH, Giovannini M, Zaehringer U, Penard-Lacronique V, Sansonetti PJ, Hugot JP, Thomas G: Geneenvironment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci USA 2003;100:3455-3460.
49. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, Fukase K, Inamura S, Kusumoto S, Hashimoto M, Foster SJ, Moran AP, Fernandez-Luna JL, Nunez G: Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003;278:5509-5512.
50. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ: Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003;278:8869-8872.
51. Bouma G, Strober W: The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;521-533.
52. Wehkamp J, Harder J, Weichental M, Herrlinger KR, Schmidt M, Schlee M, Nuding S, Schwab M, Schäfferle E, Stallmach A, Fellermann K, Schröder JM, Stange EF: Pathomechanismus des Morbus Crohn mit NOD-2 (CARD15) Mutation: Defiziente mukosale Defensinexpression bei intakter Zytokinexpression. Z Gastroenterol 2003;41:A741.
53. Hugot JP, Zouali H, Lesage S: Lessons to be learned from the NOD2 gene in Crohn's disease. Eur J Gastroenterol Hepatol 2003;15:593-597.
54. Gasche C, Alizadeh BZ, Pena AS: Genotypephenotype correlations: How many disorders constitute inflammatory bowel disease? Eur J Gastroenterol Hepatol 2003;15:599-606.
55. Lee JC, Lennard-Jones JE: Inflammatory bowel disease in 67 families each with three or more affected first-degree relatives. Gastroenterology 1996;111:587-596.
56. Bayless TM, Tokayer AZ, Polito JM 2nd, Quaskey SA, Mellits ED, Harris ML: Crohn's disease: Concordance for site and clinical type in affected family members - Potential hereditary influences. Gastroenterology 1996;111:573-579.
57. Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S, Jahnsen J, Moum B, Klump B, Krawczak M, Mirza MM, Foelsch UR, Vatn M, Schreiber S: Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: A cohort study. Lancet 2002;359:1661-1665.
58. Helio T, Halme L, Lappalainen M, Fodstad H, Paavola-Sakki P, Turunen U, Farkkila M, Krusius T, Kontula K: CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut 2003;52:558-562.
59. Abreu MT, Taylor KD, Lin YC, Hang T, Gaiennie J, Landers CJ, Vasiliauskas EA, Kam LY, Rojany M, Papadakis KA, Rotter JI, Targan SR, Yang H: Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002;123:679-688.
60. Louis E, Michel V, Hugot JP, Reenaers C, Fontaine F, Delforge M, El Yafi F, Colombel JF, Belaiche J: Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 2003;52:552-557.
61. Fidder HH, Olschwang S, Avidan B, Zouali H, Lang A, Bardan E, Picard O, Bar-Meir S, Colombel JF, Chowers Y: Association between mutations in the CARD15 (NOD2) gene and Crohn's disease in Israeli Jewish patients. Am J Med Genet 2003;121:240-244.
62. Vermeire S, Louis E, Rutgeerts P, De Vos M, Van Gossum A, Belaiche J, Pescatore P, Fiasse R, Pelckmans P, Vlietinck R, Merlin F, Zouali H, Thomas G, Colombel JF, Hugot JP: Belgian Group of Infliximab Expanded Access Program and Fondation Jean Dausset CEPH, Paris, France: NOD2/CARD15 does not influence response to infliximab in Crohn's disease. Gastroenterology 2002;123:106-111.
63. Mascheretti S, Hampe J, Croucher PJ, Nikolaus S, Andus T, Schubert S, Olson A, Bao W, Fölsch UR, Schreiber S: Response to infliximab treatment in Crohn's disease is not associated with mutations in the CARD15 (NOD2) gene: An analysis in 534 patients from two multicenter, prospective GCP-level trials. Pharmacogenetics 2002;12:509-515.
64. Sartor RB: Clinical applications of advances in the genetics of IBD. Rev Gastroenterol Disord 2003;3(suppl 1):S9-S17.
65. Folwaczny C, Glas J, Torok HP: Crohn's disease: An immunodeficiency? Eur J Gastroenterol Hepatol 2003;15:621-626.